Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited provided earnings guidance for the year ended December 31, 2018. According to preliminary statistics of its financial department, the company predicted the net profit belonging to shareholders of the lcompany in 2018 will be between RMB 3.25 billion and RMB 3.9 billion, with an increase of between RMB 1,188,350,000 and RMB 1,838,350,000 compared with the same period of the year before and with a year-on-year increase of between 57.64% and 89.17% (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be between RMB 1,955,000,000 and RMB 2,581,000,000, with an increase of between RMB 19.44 million and RMB 645.44 million compared with the same period of the year before and with a year-on-year increase of between 1.00% and 33.35%.